A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

Details

Language :

English

ISSN :

03618609

Volume :

92

Issue :

5

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

122452260

Full Text :

https://doi.org/10.1002/ajh.24693